search
Back to results

Midlevel Versus Physician-provided Medical Abortion in the Second Trimester

Primary Purpose

Induced Abortion, Second Trimester Abortion, Medical Abortion

Status
Completed
Phase
Not Applicable
Locations
Ethiopia
Study Type
Interventional
Intervention
Provider type: Physicians
Provider type: Midlevel Providers
Sponsored by
Ipas
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Induced Abortion focused on measuring Midlevel provider

Eligibility Criteria

16 Years - undefined (Child, Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Willing and able to give consent for participation
  • Intrauterine pregnancy with confirmed gestational age >13 weeks and <20 weeks
  • Presenting for induced abortion at Michu Clinic
  • Speaker of Amharic or Oromo

Exclusion Criteria:

  • Women unable to give consent for participation
  • Gestational age <13 or >20 weeks
  • Adolescents aged less than 16 years
  • Women with an allergy to or contraindications to mifepristone or misoprostol
  • Women with a history of more than one previous hysterotomy
  • Women seeking treatment for incomplete abortion, intrauterine fetal demise, or postabortion care
  • Women with chronic hypertension or adrenal failure
  • Women on chronic steroid treatment

Sites / Locations

  • St. Paul's Hospital Millennium Medical College

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Women receiving abortion care by physicians

Women receiving abortion care from midlevel providers

Arm Description

Patients who receive second trimester medical abortion care from a physician.

Patients who receive second trimester medical abortion care from a midlevel provider.

Outcomes

Primary Outcome Measures

Time to expulsion
Time to expulsion of fetus after medical abortion regimen initiated

Secondary Outcome Measures

Total number of misoprostol doses
Doses of misoprostol needed for completion of abortion
Need for ultrasound to confirm gestational age
Whether ultrasound was needed to estimate gestational age
Need for intervention by a physician
whether any physician involvement was needed to manage the case (from nurse-led services)
Serious complications/ morbidity
Whether the following complications occur while a patient is receiving abortion services: hemorrhage requiring transfusion, placental retention requiring removal, uterine rupture, fever/ signs of infection requiring antibiotic treatment.
Adverse events
Whether adverse events occurred that required a return to the hospital after discharge from Michu clinic.

Full Information

First Posted
November 22, 2019
Last Updated
September 17, 2021
Sponsor
Ipas
Collaborators
St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia
search

1. Study Identification

Unique Protocol Identification Number
NCT04181541
Brief Title
Midlevel Versus Physician-provided Medical Abortion in the Second Trimester
Official Title
Can Midlevel Providers Manage Medical Abortion in the Second Trimester as Safely and Effectively as Physicians? A Randomized Controlled Trial in Ethiopia
Study Type
Interventional

2. Study Status

Record Verification Date
September 2021
Overall Recruitment Status
Completed
Study Start Date
February 17, 2020 (Actual)
Primary Completion Date
February 24, 2021 (Actual)
Study Completion Date
March 3, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Ipas
Collaborators
St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of the study is to determine the safety and effectiveness of second trimester medical abortion when provided by nurse midwives compared with physicians. The study sample will be obtained from Michu Clinic, affiliated with St Paul's hospital, in Addis Ababa.
Detailed Description
About 10% of all abortions globally take place at or after 13 weeks gestation. Women seeking second-trimester abortion services are often the most vulnerable and socially disadvantaged population.Studies show the rate of second-trimester abortion procedures remains stable over time, even in high-access locations, confirming the ongoing need for accessibility to services in rural locations with limited access to care. In Ethiopia, second-trimester abortion services are widely available in Addis Ababa, making up a high proportion of the total number of abortions occurring each year in the country; however, access to accurate and reliable data is limited. The World Health Organization recommends that abortion can be provided at the lowest level of the healthcare system (WHO abortion guidelines). Training mid-level providers, such as midwives, nurses and other non-physician providers, to conduct second trimester aspiration abortions is proposed as a way to increase women's access to safe abortion procedures and has been highlighted by the WHO as an area in which rigorous research is needed (WHO task-sharing guidelines). The investigators seek to conduct a comparative study of patients undergoing second trimester medical abortion provided by either physicians or nurse midwives.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Induced Abortion, Second Trimester Abortion, Medical Abortion, Health Personnel
Keywords
Midlevel provider

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The investigators propose a randomized, controlled, non-inferiority study comparing management of medical abortion by either nurse midwives or physicians for women undergoing induced abortion at a gestational ages > 13 weeks.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
245 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Women receiving abortion care by physicians
Arm Type
Active Comparator
Arm Description
Patients who receive second trimester medical abortion care from a physician.
Arm Title
Women receiving abortion care from midlevel providers
Arm Type
Experimental
Arm Description
Patients who receive second trimester medical abortion care from a midlevel provider.
Intervention Type
Procedure
Intervention Name(s)
Provider type: Physicians
Intervention Description
In this cohort, women will receive second trimester medical abortion care from physicians
Intervention Type
Procedure
Intervention Name(s)
Provider type: Midlevel Providers
Intervention Description
In this cohort, women will receive second trimester medical abortion care from midlevel providers.
Primary Outcome Measure Information:
Title
Time to expulsion
Description
Time to expulsion of fetus after medical abortion regimen initiated
Time Frame
Time (hours/minutes) from first dose of misoprostol until the fetus is expelled, up to 72 hours
Secondary Outcome Measure Information:
Title
Total number of misoprostol doses
Description
Doses of misoprostol needed for completion of abortion
Time Frame
Time (hours/minutes) from first dose of misoprostol until the fetus and placenta are expelled, up to 72 hours
Title
Need for ultrasound to confirm gestational age
Description
Whether ultrasound was needed to estimate gestational age
Time Frame
At the time of eligibility for the abortion is assessed, need for confirmatory ultrasound recorded (up to 1 day)
Title
Need for intervention by a physician
Description
whether any physician involvement was needed to manage the case (from nurse-led services)
Time Frame
Assessed at the time of discharge and reflecting entire duration of hospitalization (up to 7 days)
Title
Serious complications/ morbidity
Description
Whether the following complications occur while a patient is receiving abortion services: hemorrhage requiring transfusion, placental retention requiring removal, uterine rupture, fever/ signs of infection requiring antibiotic treatment.
Time Frame
Assessed at the time of discharge and reflecting entire duration of hospitalization (up to 7 days)
Title
Adverse events
Description
Whether adverse events occurred that required a return to the hospital after discharge from Michu clinic.
Time Frame
up to 7 days after discharge

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
16 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Willing and able to give consent for participation Intrauterine pregnancy with confirmed gestational age >13 weeks and <20 weeks Presenting for induced abortion at Michu Clinic Speaker of Amharic or Oromo Exclusion Criteria: Women unable to give consent for participation Gestational age <13 or >20 weeks Adolescents aged less than 16 years Women with an allergy to or contraindications to mifepristone or misoprostol Women with a history of more than one previous hysterotomy Women seeking treatment for incomplete abortion, intrauterine fetal demise, or postabortion care Women with chronic hypertension or adrenal failure Women on chronic steroid treatment
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nathalie Kapp, MD, MPH
Organizational Affiliation
Ipas
Official's Role
Principal Investigator
Facility Information:
Facility Name
St. Paul's Hospital Millennium Medical College
City
Addis Ababa
Country
Ethiopia

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Midlevel Versus Physician-provided Medical Abortion in the Second Trimester

We'll reach out to this number within 24 hrs